Evidence map›Paper›PMID 41238775›Full record

ArticleNature cancer2025

Characterization of the tumor microbiome of brain metastases and glioblastoma reveals tumor-type-specific and location-specific microbial signatures.

Elinor Gigi, Nancy Gavert, Lilach Raijman-Nagar, Yaara Zwang, Hofit Zemach, Ilana Livyatan, Adva Levy-Barda, Yossi Laviv, Andrew A Kanner, Alexandra Amiel and 20 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Elinor GigiDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Nancy GavertDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0003-1639-4684
Lilach Raijman-NagarDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Yaara ZwangDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0002-5387-4663
Hofit ZemachDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Ilana LivyatanDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Adva Levy-BardaBiobank, Department of Pathology, Rabin Medical Center, Petah Tikva, Israel.
Yossi LavivDepartment of Neurosurgery, Rabin Medical Center, Petah Tikva, Israel.
Andrew A KannerDepartment of Neurosurgery, Rabin Medical Center, Petah Tikva, Israel.ORCID http://orcid.org/0000-0002-0812-8573
Alexandra AmielNeuro-Oncology Unit, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.
Tali SiegalNeuro-Oncology Unit, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.
Anca LeiboviciDepartment of Oncology, Galilee Medical Center, Nahariya, Israel.
Inna SelezenDepartment of Pathology, Galilee Medical Center, Nahariya, Israel.
Omar BadranOncology Institute, Haemek medical Center, Afula, Israel.
Yaniv ZoharRappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
Esraa SafadiOncology wing, RAMBAM Health Care Campus, Haifa, Israel.
Lyndsey L PratherDepartment of Neurology and Neurosurgery, Baylor College of Medicine, Houston, TX, USA.
Cassandra R HelferDepartment of Neurology, Northwestern University, Chicago, IL, USA.
Patricia CastroDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.ORCID http://orcid.org/0000-0001-5286-8037
Iris BarshackGray Faculty of Medical & Health Sciences, Tel-Aviv University, Tel Aviv, Israel.
Tali DadoshDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel.
Smadar Levin-ZaidmanDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel.
Inna GoliandDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Ofra GolaniDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0002-9793-236X
Suzana HornGray Faculty of Medical & Health Sciences, Tel-Aviv University, Tel Aviv, Israel.
Jacob J MandelDepartment of Neurology and Neurosurgery, Baylor College of Medicine, Houston, TX, USA.
Noam ShentalDepartment of Mathematics and Computer Science, The Open University of Israel, Ra'anana, Israel.
Ayelet Shai *Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.ORCID http://orcid.org/0000-0001-9502-8441
Shlomit Yust-Katz *Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Tel Aviv, Israel.
Ravid Straussman *Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. ravidst@weizmann.ac.il.ORCID http://orcid.org/0000-0002-9476-329X

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 818086Israel Cancer Research Fund (Israel Cancer Research Fund, Inc.) 22-109-PGIsrael Science Foundation (ISF) 2927/21
6 · The paper itself

Abstract

Brain tumors, including glioblastoma multiforme (GBM) and brain metastases, present a notable clinical challenge. Recent research highlights the presence of intratumor bacteria across many tumor types, yet the microbiome of brain tumors remains largely underexplored. Here we show that the microbiome of 322 brain tumors differs markedly by tumor type and location. Using multiple approaches to visualize, culture and sequence bacterial communities, we found that brain metastases harbor higher bacterial richness and diversity than GBM, with distinct microbial compositions. Moreover, metastases in posterior brain regions exhibited greater diversity than those in anterior regions. Pathway analysis revealed enrichment of bacterial metabolic pathways associated with tumor spread and metastasis in brain metastases while GBM was enriched with pathways supporting alternative phosphorus use. These findings provide valuable insights into the microbial landscape of brain tumors, highlighting tumor-type-specific and location-specific variation and suggesting potential roles for bacteria in brain tumor biology.

Indexed as

Brain NeoplasmsGlioblastomaMicrobiotaBacteriaFemaleHumansMaleMiddle Aged

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.